Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone.
- DOI
- 10.1007/s00277-008-0538-0
- Published
- 2009 Feb
- Container
- Annals of hematology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00277-008-0538-0,
title = {Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone.},
author = {Trappe R and Riess H and Anagnostopoulos I and Neuhaus R and Gärtner BC and Pohl H and Müller HP and Jonas S and Papp-Vary M and Oertel S},
year = {2009},
journal = {Annals of hematology},
doi = {10.1007/s00277-008-0538-0},
url = {https://doi.org/10.1007/s00277-008-0538-0}
}RIS
TY - JOUR TI - Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone. AU - Trappe R AU - Riess H AU - Anagnostopoulos I AU - Neuhaus R AU - Gärtner BC AU - Pohl H AU - Müller HP AU - Jonas S AU - Papp-Vary M AU - Oertel S PY - 2009 JO - Annals of hematology DO - 10.1007/s00277-008-0538-0 UR - https://doi.org/10.1007/s00277-008-0538-0 ER -
APA
R, T., H, R., I, A., R, N., BC, G., H, P., HP, M., S, J., M, P., & S, O. (2009). Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone.. Annals of hematology. https://doi.org/10.1007/s00277-008-0538-0
Source records
- pubmed · retrieved 2026-09-25T14:38:27.118Z
- europe-pmc · retrieved 2026-09-25T14:38:27.130Z
- hal · retrieved 2026-09-25T14:38:27.191Z